Skip to main content
Top
Published in: Annals of Surgical Oncology 13/2021

01-12-2021 | Metastasis | Pediatric Oncology

Value of the Sentinel Node Procedure in Pediatric Extremity Rhabdomyosarcoma: A Systematic Review and Retrospective Cohort Study

Authors: Bernadette Jeremiasse, MSc, MD, Alida F. W. van der Steeg, PhD, MD, Marta Fiocco, PhD, Monique G. G. Hobbelink, PhD, MD, Johannes H. M. Merks, PhD, MD, Jan Godzinski, PhD, MD, Barry L. Shulkin, MSc, MD, Marc H. W. A. Wijnen, MD, Cecilia E. J. Terwisscha van Scheltinga, MSc, MD

Published in: Annals of Surgical Oncology | Issue 13/2021

Login to get access

Abstract

Background

Our aim is to show whether the sentinel node procedure (SNP) is recommendable for pediatric patients with extremity rhabdomyosarcoma (RMS). Lymph node metastases are an important prognostic factor in pediatric patients with extremity RMS. Accurate nodal staging is necessary to treat the patient accordingly. An alternative to the current recommended lymph node sampling is the sentinel node procedure (SNP).

Methods

A systematic review was performed summarizing all published cases of SNP in addition to 13 cases from our hospital and 8 cases from two other hospitals that have not been published before.

Results

For all patients (n = 55), at least one SLN was identified, but the SNP technique used was not uniform. The SNP changed the nodal classification of eight patients (17.0%) and had a false-negative rate of 10.5%.

Conclusions

The SNP is recommendable for pediatric patients with extremity RMS. It can change lymph node status and can be used to sample patients in a more targeted way than nodal sampling alone. Therefore, we recommend use of the SNP in addition to clinical and radiological nodal assessment for pediatric patients with extremity RMS.
Appendix
Available only for authorised users
Literature
1.
go back to reference Dasgupta R, Fuchs J, Rodeberg D. Rhabdomyosarcoma. Semin Pediatr Surg. 2016;25(5):276–83.CrossRef Dasgupta R, Fuchs J, Rodeberg D. Rhabdomyosarcoma. Semin Pediatr Surg. 2016;25(5):276–83.CrossRef
2.
go back to reference La TH, Wolden SL, Rodeberg DA, et al. Regional nodal involvement and patterns of spread along in-transit pathways in children with rhabdomyosarcoma of the extremity: a report from the Children’s Oncology Group. Int J Radiat Oncol Biol Phys. 2011;80(4):1151–7.CrossRef La TH, Wolden SL, Rodeberg DA, et al. Regional nodal involvement and patterns of spread along in-transit pathways in children with rhabdomyosarcoma of the extremity: a report from the Children’s Oncology Group. Int J Radiat Oncol Biol Phys. 2011;80(4):1151–7.CrossRef
3.
go back to reference Rodeberg DA, Garcia-Henriquez N, Lyden ER, et al. Prognostic significance and tumor biology of regional lymph node disease in patients with rhabdomyosarcoma: a report from the Children’s Oncology Group. J Clin Oncol. 2011;29(10):1304–11.CrossRef Rodeberg DA, Garcia-Henriquez N, Lyden ER, et al. Prognostic significance and tumor biology of regional lymph node disease in patients with rhabdomyosarcoma: a report from the Children’s Oncology Group. J Clin Oncol. 2011;29(10):1304–11.CrossRef
4.
go back to reference Wagner LM, Kremer N, Gelfand MJ, et al. Detection of lymph node metastases in pediatric and adolescent/young adult sarcoma: Sentinel lymph node biopsy versus fludeoxyglucose positron emission tomography imaging—a prospective trial. Cancer. 2017;123(1):155–60.CrossRef Wagner LM, Kremer N, Gelfand MJ, et al. Detection of lymph node metastases in pediatric and adolescent/young adult sarcoma: Sentinel lymph node biopsy versus fludeoxyglucose positron emission tomography imaging—a prospective trial. Cancer. 2017;123(1):155–60.CrossRef
5.
go back to reference Terwisscha van Scheltinga SEJ, Wijnen M, Martelli H, et al. Local staging and treatment in extremity rhabdomyosarcoma—a report from the EpSSG-RMS2005 study. Cancer Med. 2020;9(20):7580–9.CrossRef Terwisscha van Scheltinga SEJ, Wijnen M, Martelli H, et al. Local staging and treatment in extremity rhabdomyosarcoma—a report from the EpSSG-RMS2005 study. Cancer Med. 2020;9(20):7580–9.CrossRef
6.
go back to reference Oberlin O, Rey A, Brown KL, et al. Prognostic factors for outcome in localized extremity rhabdomyosarcoma. Pooled analysis from four international cooperative groups. Pediatr Blood Cancer. 2015;62(12):2125–31.CrossRef Oberlin O, Rey A, Brown KL, et al. Prognostic factors for outcome in localized extremity rhabdomyosarcoma. Pooled analysis from four international cooperative groups. Pediatr Blood Cancer. 2015;62(12):2125–31.CrossRef
7.
go back to reference Terwisscha van Scheltinga CE, Spronk P, van Rosmalen J, et al. Diagnosis and treatment of lymph node metastases in pediatric rhabdomyosarcoma in the Netherlands: a retrospective analysis. J Pediatr Surg. 2014;49(3):416–9.CrossRef Terwisscha van Scheltinga CE, Spronk P, van Rosmalen J, et al. Diagnosis and treatment of lymph node metastases in pediatric rhabdomyosarcoma in the Netherlands: a retrospective analysis. J Pediatr Surg. 2014;49(3):416–9.CrossRef
8.
go back to reference Neville HL, Andrassy RJ, Lobe TE, et al. Preoperative staging, prognostic factors, and outcome for extremity rhabdomyosarcoma: a preliminary report from the Intergroup Rhabdomyosarcoma Study IV (1991–1997). J Pediatr Surg. 2000;35(2):317–21.CrossRef Neville HL, Andrassy RJ, Lobe TE, et al. Preoperative staging, prognostic factors, and outcome for extremity rhabdomyosarcoma: a preliminary report from the Intergroup Rhabdomyosarcoma Study IV (1991–1997). J Pediatr Surg. 2000;35(2):317–21.CrossRef
9.
go back to reference Lobeck I, Dupree P, Karns R, Rodeberg D, von Allmen D, Dasgupta R. Quality assessment of lymph node sampling in rhabdomyosarcoma: a surveillance, epidemiology, and end results (SEER) program study. J Pediatr Surg. 2017;52(4):614–7.CrossRef Lobeck I, Dupree P, Karns R, Rodeberg D, von Allmen D, Dasgupta R. Quality assessment of lymph node sampling in rhabdomyosarcoma: a surveillance, epidemiology, and end results (SEER) program study. J Pediatr Surg. 2017;52(4):614–7.CrossRef
10.
go back to reference Giuliano AE, Ballman K, McCall L, et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: long-term follow-up from the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 Randomized Trial. Ann Surg. 2016;264(3):413–20.CrossRef Giuliano AE, Ballman K, McCall L, et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: long-term follow-up from the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 Randomized Trial. Ann Surg. 2016;264(3):413–20.CrossRef
11.
go back to reference Morton DL, Cochran AJ, Thompson JF, et al. Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial. Ann Surg. 2005;242(3):302–11.CrossRef Morton DL, Cochran AJ, Thompson JF, et al. Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial. Ann Surg. 2005;242(3):302–11.CrossRef
12.
go back to reference Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.CrossRef Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.CrossRef
13.
go back to reference Wong SL, Balch CM, Hurley P, et al. Sentinel lymph node biopsy for melanoma: American Society of Clinical Oncology and Society of Surgical Oncology joint clinical practice guideline. J Clin Oncol. 2012;30(23):2912–8.CrossRef Wong SL, Balch CM, Hurley P, et al. Sentinel lymph node biopsy for melanoma: American Society of Clinical Oncology and Society of Surgical Oncology joint clinical practice guideline. J Clin Oncol. 2012;30(23):2912–8.CrossRef
14.
go back to reference Cheng G, Kurita S, Torigian DA, Alavi A. Current status of sentinel lymph-node biopsy in patients with breast cancer. Eur J Nucl Med Mol Imag. 2011;38(3):562–75.CrossRef Cheng G, Kurita S, Torigian DA, Alavi A. Current status of sentinel lymph-node biopsy in patients with breast cancer. Eur J Nucl Med Mol Imag. 2011;38(3):562–75.CrossRef
15.
go back to reference Wright S, Armeson K, Hill EG, et al. The role of sentinel lymph node biopsy in select sarcoma patients: a meta-analysis. Am J Surg. 2012;204(4):428–33.CrossRef Wright S, Armeson K, Hill EG, et al. The role of sentinel lymph node biopsy in select sarcoma patients: a meta-analysis. Am J Surg. 2012;204(4):428–33.CrossRef
16.
go back to reference Kaplan EL, Meier P. Nonparametric estimation from incomplete observation. J Am Stat Assoc. 1958;53:457–81.CrossRef Kaplan EL, Meier P. Nonparametric estimation from incomplete observation. J Am Stat Assoc. 1958;53:457–81.CrossRef
17.
go back to reference Dall’Igna P, De Corti F, Alaggio R, Cecchetto G. Sentinel node biopsy in pediatric patients: the experience in a single institution. Eur J Pediatr Surg. 2014;24(6):482–7.CrossRef Dall’Igna P, De Corti F, Alaggio R, Cecchetto G. Sentinel node biopsy in pediatric patients: the experience in a single institution. Eur J Pediatr Surg. 2014;24(6):482–7.CrossRef
18.
go back to reference De Corti F, Dall’lgna P, Bisogno G, et al. Sentinel node biopsy in pediatric soft tissue sarcomas of extremities. Pediatr Blood Cancer. 2009;52(1):51–4.CrossRef De Corti F, Dall’lgna P, Bisogno G, et al. Sentinel node biopsy in pediatric soft tissue sarcomas of extremities. Pediatr Blood Cancer. 2009;52(1):51–4.CrossRef
19.
go back to reference Andreou D, Boldt H, Werner M, Hamann C, Pink D, Tunn PU. Sentinel node biopsy in soft tissue sarcoma subtypes with a high propensity for regional lymphatic spread-results of a large prospective trial. Ann Oncol. 2013;24(5):1400–5.CrossRef Andreou D, Boldt H, Werner M, Hamann C, Pink D, Tunn PU. Sentinel node biopsy in soft tissue sarcoma subtypes with a high propensity for regional lymphatic spread-results of a large prospective trial. Ann Oncol. 2013;24(5):1400–5.CrossRef
20.
go back to reference Alcorn KM, Deans KJ, Congeni A, et al. Sentinel lymph node biopsy in pediatric soft tissue sarcoma patients: utility and concordance with imaging. J Pediatr Surg. 2013;48(9):1903–6.CrossRef Alcorn KM, Deans KJ, Congeni A, et al. Sentinel lymph node biopsy in pediatric soft tissue sarcoma patients: utility and concordance with imaging. J Pediatr Surg. 2013;48(9):1903–6.CrossRef
21.
go back to reference Gow KW, Rapkin LB, Olson TA, Durham MM, Wyly B, Shehata BM. Sentinel lymph node biopsy in the pediatric population. J Pediatr Surg. 2008;43(12):2193–8.CrossRef Gow KW, Rapkin LB, Olson TA, Durham MM, Wyly B, Shehata BM. Sentinel lymph node biopsy in the pediatric population. J Pediatr Surg. 2008;43(12):2193–8.CrossRef
22.
go back to reference Kayton ML, Delgado R, Busam K, et al. Experience with 31 sentinel lymph node biopsies for sarcomas and carcinomas in pediatric patients. Cancer. 2008;112(9):2052–9.CrossRef Kayton ML, Delgado R, Busam K, et al. Experience with 31 sentinel lymph node biopsies for sarcomas and carcinomas in pediatric patients. Cancer. 2008;112(9):2052–9.CrossRef
23.
go back to reference Neville HL, Andrassy RJ, Lally KP, Corpron C, Ross MI. Lymphatic mapping with sentinel node biopsy in pediatric patients. J Pediatr Surg. 2000;35(6):961–4.CrossRef Neville HL, Andrassy RJ, Lally KP, Corpron C, Ross MI. Lymphatic mapping with sentinel node biopsy in pediatric patients. J Pediatr Surg. 2000;35(6):961–4.CrossRef
24.
go back to reference Parida L, Morrisson GT, Shammas A, et al. Role of lymphoscintigraphy and sentinel lymph node biopsy in the management of pediatric melanoma and sarcoma. Pediatr Surg Int. 2012;28(6):571–8.CrossRef Parida L, Morrisson GT, Shammas A, et al. Role of lymphoscintigraphy and sentinel lymph node biopsy in the management of pediatric melanoma and sarcoma. Pediatr Surg Int. 2012;28(6):571–8.CrossRef
25.
go back to reference McMulkin HM, Yanchar NL, Fernandez CV, Giacomantonio C. Sentinel lymph node mapping and biopsy: a potentially valuable tool in the management of childhood extremity rhabdomyosarcoma. Pediatr Surg Int. 2003;19(6):453–6.CrossRef McMulkin HM, Yanchar NL, Fernandez CV, Giacomantonio C. Sentinel lymph node mapping and biopsy: a potentially valuable tool in the management of childhood extremity rhabdomyosarcoma. Pediatr Surg Int. 2003;19(6):453–6.CrossRef
26.
go back to reference De Corti F, Dall’Igna P, Bisogno G, et al. Sentinel node biopsy in pediatric soft tissue sarcomas of extremities. Pediatr Blood Cancer. 2009;52(1):51–4.CrossRef De Corti F, Dall’Igna P, Bisogno G, et al. Sentinel node biopsy in pediatric soft tissue sarcomas of extremities. Pediatr Blood Cancer. 2009;52(1):51–4.CrossRef
27.
go back to reference Zahoor S, Haji A, Battoo A, Qurieshi M, Mir W, Shah M. Sentinel lymph node biopsy in breast cancer: a clinical review and update. J Breast Cancer. 2017;20(3):217–27.CrossRef Zahoor S, Haji A, Battoo A, Qurieshi M, Mir W, Shah M. Sentinel lymph node biopsy in breast cancer: a clinical review and update. J Breast Cancer. 2017;20(3):217–27.CrossRef
28.
go back to reference Larsen WJ. Essentials of human embryology. Edinburgh: Churchill Livingstone; 1998. Larsen WJ. Essentials of human embryology. Edinburgh: Churchill Livingstone; 1998.
Metadata
Title
Value of the Sentinel Node Procedure in Pediatric Extremity Rhabdomyosarcoma: A Systematic Review and Retrospective Cohort Study
Authors
Bernadette Jeremiasse, MSc, MD
Alida F. W. van der Steeg, PhD, MD
Marta Fiocco, PhD
Monique G. G. Hobbelink, PhD, MD
Johannes H. M. Merks, PhD, MD
Jan Godzinski, PhD, MD
Barry L. Shulkin, MSc, MD
Marc H. W. A. Wijnen, MD
Cecilia E. J. Terwisscha van Scheltinga, MSc, MD
Publication date
01-12-2021
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 13/2021
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-021-10035-9

Other articles of this Issue 13/2021

Annals of Surgical Oncology 13/2021 Go to the issue